Weiwei Yang

7.8k citations
97 papers · 5.8k indexed · 4 hit papers · h-index 29

Impact in

    • Cancer, Hypoxia, and Metabolism
    • Cancer-related molecular mechanisms research
    • RNA modifications and cancer
    • Metabolism, Diabetes, and Cancer
    • Epigenetics and DNA Methylation
    • Mitochondrial Function and Pathology
    • ATP Synthase and ATPases Research

Papers in

    • Cancer, Hypoxia, and Metabolism 27
    • Epigenetics and DNA Methylation 10
    • RNA modifications and cancer 9
    • Metabolism, Diabetes, and Cancer 7
    • Mitochondrial Function and Pathology 7
    • ATP Synthase and ATPases Research 5

Weiwei Yang

86 papers receiving 5.7k citations

Hit Papers

Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity 2023 · 118 citations
1182011202620162021250500750

Peers

Weiwei Yang
Comparison fields: 5 of 129
  • Cancer Research 2.9k
  • Molecular Biology 4.0k
  • Immunology 728
  • Oncology 914
  • Biochemistry 199
Replace Xu Qian with:
Xu Qian China
Jinliang Xing China
Jie Zhou China
Li Li China
Richard Possemato United States
Brandon Faubert United States
Goutam Ghosh Choudhury United States
Qingzhong Xiao United Kingdom
Ismael Samudio United States
Arvind Ramanathan United States
Weiwei Yang relative to Xu Qian China Xu Qian's profile →
Citations per field
00.5×1.5×1.8×
Xu Qian · 1×
Citations per year

Countries citing papers authored by Weiwei Yang

Since Specialization
Citations

This map shows the geographic impact of Weiwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Yang more than expected).

Fields of papers citing papers by Weiwei Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Yang. The network helps show where Weiwei Yang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Weiwei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weiwei Yang Line = papers co-authored together Weiwei Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20254
4 20250
5 20250
6 20250
7 202326
8 20231
9 20238
10 20234
11 20235
12
FOXO4 May Be a Biomarker of Postmenopausal Osteoporosis
20223
13 202221
14 20208
15 20201
16 20202
17 20183
18 2016262
19 2015158
20 2012219

About Weiwei Yang

Weiwei Yang is a scholar working on Cancer Research, Molecular Biology, Critical Care and Intensive Care Medicine, Immunology and Cell Biology, having authored 97 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (27 papers), Epigenetics and DNA Methylation (10 papers), RNA modifications and cancer (9 papers), Metabolism, Diabetes, and Cancer (7 papers), Mitochondrial Function and Pathology (7 papers), Microtubule and mitosis dynamics (5 papers), ATP Synthase and ATPases Research (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Cancer Research (2.9k citations), Molecular Biology (4.0k citations), Immunology (728 citations), Oncology (914 citations) and Biochemistry (199 citations). Weiwei Yang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhimin Lu, Yan Xia, Ji Liang, Kenneth Aldape, Haitao Ji, Yanhua Zheng, Xinjian Li, David H. Hawke, Zhimin Lu and Yanhua Zheng. Their work appears in journals such as Molecular Cell, Journal of Biological Chemistry, Cell Research, Nature Communications and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026